UPDATE : Tuesday, February 18, 2020
Green Cross unveils non-clinical trial data for hemophilia A treatment
Green Cross said Monday that it has presented non-clinical trial data for M...
by Lee Han-soo  |  2017-12-18 15:12
Kwangdong punished for illegal ad of obesity drug
Kwangdong Pharmaceutical has received an administrative penalty for illegal...
by Lee Hye-seon  |  2017-12-18 14:50
Yuhan’s chemo combo YH24931 more effective than immunotherapy alone
Yuhan Corp.’s combination of chemotherapy with immunotherapy YH24931 has st...
by Nam Doo-hyun  |  2017-12-18 11:51
‘Postmenopausal women in 50s shouldn’t take phytoestrogen’
Over-the-counter drugs and health functional foods to alleviate symptoms of...
by Nam Doo-hyun  |  2017-12-18 10:49
3 Korean startups using AI to develop new drugs
Korea’s biopharmaceutical industry is increasingly adopting artificial inte...
by Marian Chu  |  2017-12-15 23:00
Medytox, Hugel compete in botulinum toxin market
Medytox and Hugel have achieved a rapid growth in manufacturing botulinum t...
by So Jae-hyeon  |  2017-12-15 15:12
Parkinson’s disease treatment Azilect in robust growth
Lundbeck Korea’s Azilect (ingredient: rasagiline) is performing well in Kor...
by So Jae-hyeon  |  2017-12-15 11:36
Ildong, Abbot to tap rosuvastatin+ezetimibe combo market
Ildong Pharmaceutical and Abbot Korea are likely to try on the rosuvastatin...
by Lee Hye-seon  |  2017-12-14 15:01
Koreans in their 20s most susceptible to hepatitis A: study
New research shows nine out of 10 young adults in Korea do not have antibod...
by Marian Chu  |  2017-12-13 18:18
MGmed to change name to Cancer Rop
Korean pharmaceutical MGmed decided to change the company’s name to Cancer ...
by Marian Chu  |  2017-12-13 18:14
Syntekabio, CJ Healthcare agree to develop new drugs using AI
Syntekabio and CJ Healthcare have signed an agreement to co-develop a new i...
by Lee Han-soo  |  2017-12-13 17:17
Daewoong’s liver drug Ursa to enter US market
Daewoong Pharmaceutical said it aimed to sell its flagship product Ursa, a ...
by So Jae-hyeon  |  2017-12-13 15:23
Janssen says its multiple myeloma drug combo halves death risk
Janssen, a Johnson & Johnson division, said a combination therapy with DARZ...
by Marian Chu  |  2017-12-13 15:22
Celgene, Bluebird Bio’s CAR-T therapy proves 94% response in P1 study
Bluebird Bio and Celgene posted phase 1 results of investigational drug bb2...
by Marian Chu  |  2017-12-13 14:30
AstraZeneca to test Imfinzi on lung cancer patients
AstraZeneca is to conduct a clinical trial on anti-cancer immunotherapy Imf...
by Lee Hye-seon  |  2017-12-13 14:20
Wholesalers sweat over drug companies’ forceful sales
Local wholesalers of pharmaceutical products are experiencing distress at t...
by So Jae-hyeon  |  2017-12-13 11:33
Hanmi leads erectile dysfunction drug sales
Teva Pharmaceutical and Pfizer said Monday they will launch generic version...
by Marian Chu  |  2017-12-12 17:49
Drugmakers lead job growth in manufacturing sector
The pharmaceutical industry has led the growth of jobs in the manufacturing...
by So Jae-hyeon  |  2017-12-12 15:12
Korea approves Olumiant pills for treatment of rheumatoid arthritis
The government has approved Olumiant (ingredient: baricitinib), an oral med...
by Lee Hye-seon  |  2017-12-12 11:50
Huons wins patent for oral medication of clarithromycin
Huons, a subsidiary of Huons Global, said Tuesday that it has acquired a pa...
by Lee Han-soo  |  2017-12-12 11:41
Back to Top